Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Comment by Momentum11on Jan 06, 2018 2:23am
86 Views
Post# 27296072

RE:RE:RE:RE:RE:push down posts from pusssys like momentum & bigtime

RE:RE:RE:RE:RE:push down posts from pusssys like momentum & bigtime8 million shares being sold into the market isnt the issue. With the volume in this sector and the size of the float it isn't a huge deal. The issue is it signals that this speculative purchase of a LP will not happen. Why would the CEO be dumping that many shares when he knows they may be getting a LP? If this thing will run 3x or 10x more like you say dont you think the CEO would be holding? Keep in mind he cannot be making this trade based on future events he is aware of but he can of course hold due to future events.

He has not bought a single share in the past 3 years from what I have seen. During this time he has sold approx 16 million shares. Now most CEO's in this industry aren't buying shares because of the valuations are toppy so I dont expect him to be buying but dumping that high of a % of his owenership?

Also, they have 3 millionish in cash if they dont pay off any debt. ACG just purchased a producer in Quebec that doesn't have a license yet for 7 million in shares as an example. They arent even licensed, an actual LP is out of reach by NF. Basically any publicly traded LP has a market cap 100 million + at this point....
Bullboard Posts